Free tool
Stocks listed on Nasdaq CM
We cover 17 companies listed on Nasdaq CM. The median market value in the group is $3.19B. Across the group, the median move over the past trading day is −0.70%. Price change over the past year runs from +30.1% to +274.5% across the middle 80 percent of the group, with a median of +144.1%.
Other lists in this group
Table
17 of 1,344 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| TGTX | TG Therapeutics, Inc. Common Stock | $55.03 | +0.29% | +87.94% | +92.61% |
| BLTE | Belite Bio, Inc | $156.69 | +0.47% | −1.62% | +144.07% |
| LQDA | Liquidia Corporation | $71.36 | −17.81% | +127.26% | +154.86% |
| DNTH | Dianthus Therapeutics, Inc. | $110.76 | +9.01% | +179.13% | +356.93% |
| CELC | Celcuity Inc. | $95.08 | +15.30% | −5.44% | +90.31% |
| VKTX | Viking Therapeutics, Inc. | $34.38 | +1.54% | −2.94% | +29.15% |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| CLDX | Celldex Therapeutics, Inc. | $40.57 | +14.02% | +50.20% | +79.51% |
| SLS | SELLAS Life Sciences Group, Inc. | $13.73 | +36.08% | +215.63% | +615.10% |
| VRDN | Viridian Therapeutics, Inc. | $24.26 | +24.35% | −20.93% | +30.71% |
| RGC | Regencell Bioscience Holdings Limited | $5.50 | −7.87% | −73.22% | −61.38% |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% |
| NKTR | Nektar Therapeutics | $73.77 | +4.24% | +69.90% | +151.95% |
| UFPT | UFP Technologies, Inc. | $304.57 | +18.02% | +36.33% | +41.94% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| ESTA | Establishment Labs Holdings Inc. | $72.45 | −21.16% | +5.24% | +70.71% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.